Nanocarriers for Cancer Diagnosis and Targeted Chemotherapy

Muhammad Raza Shah is a full professor at the International Center for Chemical and Biological Sciences, HEJ Research Institute of Chemistry, University of Karachi, Pakistan. He is also the Head of the Center for Bioequivalence Studies and Clinical Research. He is a recipient of several awards, including the Tamgha-i-Imtiaz Award from the President of Pakistan, the Salam Prize, the Professor Atta ur Rahman Gold Medal, and the Dr M Raziuddin Siddiqi Prize, by the Pakistan Academy of Sciences, for scientists under 40 years of age, in the field of chemistry. Professor Shah has authored six books and edited four books, in addition to contributing over 350 peer-reviewed journal papers. One of his authored books was declared as best book of 2017 by the Government of Pakistan’s Higher Education Commission. Muhammad Imran is a graduate student and based at the International Center for Chemical and Biological Sciences, H.E.J. Research Institute of Chemistry University of Karachi, Pakistan. Shafi Ullah is a graduate student and based at the International Center for Chemical and Biological Sciences, H.E.J. Research Institute of Chemistry University of Karachi, Pakistan.

• 1. Potential physical and biological barriers leading to failure of cancer chemotherapy2. Nanotechnological strategies involved in the targeted delivery of anti-cancer drugs3. Liposome based targeted delivery of anticancer drugs and effective therapy of tumors4. Organic ligands as nanocarrier for targeted delivery of mediated active drug targeting for liver cancer5. Surface functionalized magnetic nanoparticles in cancer drugs delivery and diagnosis6. Nano-carriers based targeted pulmonary delivery: Novel approaches for effective lung cancer treatment7. Enhancing therapeutic efficacy of anticancer drugs through functionalized niosomes targeting8. Carbon nanotubes: Versatile nanocarriers for effective delivery of anti-cancer drugs9. Construction of stimulus responsive micelles systems for efficient targeting of cancer drugs10. Nano-targeted radiopharmaceuticals for cancer diagnosis and treatment11. Potential role of gold nanoparticles in cancer diagnosis and targeted drug delivery